|
시장보고서
상품코드
1972950
골반 장기 탈출증 교정술 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Pelvic Organ Prolapse Repair Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
세계 골반 장기 탈출증(POP) 치료 시장 규모는 2026년 4,782억 달러에 달하고, 2033년까지 7,855억 달러로 확대될 것으로 예측됩니다. CAGR은 5.10%를 나타낼 것으로 예측됩니다. POP는 골반저근육의 약화로 인해 방광, 자궁, 직장 등 골반 내 장기가 질관 내로, 혹은 질관 밖으로 하강하는 병입니다. 이 질환은 여성의 삶의 질에 심각한 영향을 미치며, 불편감, 배뇨 장애, 운동 기능 장애를 유발합니다. 인식 증가, 의료 접근성 확대, 치료법의 발전이 효과적인 POP 치료 솔루션에 대한 세계 수요를 주도하고 있습니다.
시장 인사이트
이 시장은 외과적 개입과 비외과적 개입 모두에 대한 선호도가 높아지는 것이 특징입니다. 경증에서 중등도의 경우, 페서리 및 골반저근육군 치료를 포함한 비수술적 치료가 1차적인 치료법입니다. 한편, 심한 경우에는 질폐쇄술, 질봉합술, 천골질 고정술, 자궁천골인대 고정술 등의 수술적 처치가 우선적으로 시행됩니다. 최소침습 수술 기술, 로봇 보조 수술, 생체적합성 수술용 메쉬의 혁신으로 환자의 치료 정확도, 안전성, 회복 결과가 향상되고 있습니다.
또한, 여성 건강에 대한 관심 증가와 치료 장비 및 재료에 대한 지속적인 연구 개발로 인해 자궁탈출증은 부인과 의료 분야에서 빠르게 진화하는 분야로 자리매김하고 있습니다. 기술적으로 진보된 솔루션의 도입은 치료 효과 향상, 합병증 감소, 수술 후 재활 기간 단축을 보장하여 전체 시장 성장에 기여하고 있습니다.
성장 촉진요인
POP 복원 시장의 확대를 촉진하는 요인은 다음과 같습니다.
- 여성 인구의 고령화: 전 세계적으로 고령 여성 인구가 증가함에 따라 POP의 유병률이 증가하고 있으며, 교정치료에 대한 수요가 증가하고 있습니다.
- 기술적 진보: 수술 장비, 최소침습 기술, 골반저 재활 장비의 혁신으로 치료 결과가 향상되고 있습니다.
- 인식과 교육: 여성 골반 건강에 대한 인식이 높아지면서 조기 진단과 치료 도입이 촉진되고 있습니다.
- 의료 인프라 정비: 병원 및 여성 전문 의료시설의 확충으로 고급 POP 복원치료에 대한 접근성이 향상되고 있습니다.
- 보존적 치료 선호: 페서리, 골반저근육 훈련 등 비수술적 치료법에 대한 수용도가 높아지면서 다양한 솔루션이 도입되고 있습니다.
비즈니스 기회
POP 수리 시장은 의료기기 제조업체, 의료 서비스 제공업체, 투자자들에게 많은 기회를 제공합니다.
- 신흥 시장 : 아시아태평양, 라틴아메리카 등의 지역에서는 의료 투자 증가와 인식 개선 활동으로 인해 성장이 예상됩니다.
- 제품 혁신 : 인체공학적 페서리, 생체적합성 수술용 메쉬, 로봇 보조 수술기구의 개발로 차별화의 기회를 창출합니다.
- 전략적 제휴: 의료기기 제조업체와 의료 서비스 제공업체의 협력은 시장 침투를 가속화합니다.
- 홈케어: 원격의료를 활용한 골반저부 치료와 가정용 의료기기는 환자 치료의 새로운 경로를 창출합니다.
지역별 분석
- 북미: 선진화된 의료 인프라, 높은 인식, 저침습 수술의 조기 도입에 힘입어 시장을 선도하고 있습니다.
- 유럽: 성숙한 시장으로, 수술적 혁신, 유리한 상환 정책, 강력한 연구 이니셔티브가 특징인 성숙한 시장입니다.
- 아시아태평양: 고령화 인구 증가, 인식 개선 캠페인, 전문 의료 서비스 접근성 향상으로 빠른 성장이 예상됩니다.
- 중남미: 의료 인프라 확충, 의료비 부담 경감, 여성 건강 지원을 위한 정부 정책으로 성장이 예상됩니다.
- 중동 및 아프리카(MEA) : 의료시설 및 여성 전문 케어 서비스에 대한 투자가 증가함에 따라 시장이 점차 발전하고 있습니다.
주요 기업
세계 POP 복원 시장을 형성하는 주요 기업으로는 다음과 같은 기업들이 있습니다.
- Johnson & Johnson Services, Inc.
- Coloplast A/S
- Dipromed Srl
- Boston Scientific Corporation(American Medical Systems Inc.)
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
- Cook Medical
- MEDGYN PRODUCTS, INC.
- CooperSurgical, Inc.
- DIMA S.L.
- Digitimer Ltd
- Bray Group Ltd
- medesign Ingenieur-Consulting GmbH
- Panpac Medical Corp.
- for.me.sa.
- Bioteque America Inc.
- Bliss GVS Pharma
- Panpac Medical Corporation
- Personal Medical Corporation
- Dr. Arabin GmbH & Co.
- Kangge Medical
- Integra Lifesciences
- Wallach Surgical Devices
- Medesign
시장 세분화
치료별
- 비수술적
- 페서리
- 골반저근 치료
- 수술적
- 질 폐쇄술
- 질 성형술
- 천골질 고정술
- 천골 자궁 고정술
- 자궁천골 인대 고정술
용도별
- 방광류
- 요도류
- 장류
- 자궁탈출증
- 후질벽탈장(직장탈장)
최종 사용자별
- 병원
- 전문 클리닉
- 여성 케어 시설
지역별
- 북미
- 라틴아메리카
- 유럽
- 아시아태평양
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
- 시장 정의와 세분화
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 시장 기회
- 밸류체인 분석
- COVID-19의 영향 분석
- Porter의 Five Forces 분석
- 러시아·우크라이나 분쟁의 영향
- PESTLE 분석
- 규제 분석
- 가격 동향 분석
- 현재 가격과 향후 예측, 2025년-2033년
- 가격 영향요인
제3장 세계의 골반 장기 탈출증 교정술 시장 전망, 2020년-2033년
- 세계의 골반 장기 탈출증 교정술 시장 전망, 치료별, 금액(10억 달러), 2020년-2033년
- 비수술적
- 페서리
- 골반저근 치료
- 수술적
- 질 폐쇄술
- 질 성형술
- 천골질 고정술
- 천골 자궁 고정술
- 자궁천골 인대 고정술
- 세계의 골반 장기 탈출증 교정술 시장 전망, 용도별, 금액(10억 달러), 2020년-2033년
- 방광혹
- 요도혹
- 소장혹
- 자궁탈
- 후질벽탈출(직장 하수)
- 세계의 골반 장기 탈출증 교정술 시장 전망, 최종사용자별, 금액(10억 달러), 2020년-2033년
- 병원
- 전문 클리닉
- 여성 요양시설
- 세계의 골반 장기 탈출증 교정술 시장 전망, 지역별, 금액(10억 달러), 2020년-2033년
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
제4장 북미 골반 장기 탈출증 교정술 시장 전망, 2020년-2033년
제5장 유럽 골반 장기 탈출증 교정술 시장 전망, 2020년-2033년
제6장 아시아태평양 골반 장기 탈출증 교정술 시장 전망, 2020년-2033년
제7장 라틴아메리카 골반 장기 탈출증 교정술 시장 전망, 2020년-2033년
제8장 중동 및 아프리카 골반 장기 탈출증 교정술 시장 전망, 2020년-2033년
제9장 경쟁 구도
- 기업대 부문 히트맵
- 기업의 시장 점유율 분석, 2025년
- 경쟁 대시보드
- 기업 개요
- Johnson & Johnson Services, Inc.
- Coloplast A/S
- Dipromed Srl
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
- Cook Medical
- MEDGYN PRODUCTS, INC.
- CooperSurgical, Inc.
제10장 부록
LSHThe global Pelvic Organ Prolapse (POP) Repair Market is witnessing strong growth, projected to reach USD 478.2 billion in 2026 and escalate to USD 785.5 billion by 2033, registering a CAGR of 5.10%. POP is a medical condition where pelvic organs, such as the bladder, uterus, or rectum, descend into or outside the vaginal canal due to weakened pelvic floor muscles. This condition significantly affects women's quality of life, leading to discomfort, urinary issues, and mobility challenges. Rising awareness, increasing healthcare access, and advances in treatment methods are driving the demand for effective POP repair solutions globally.
Market Insights
The market is characterized by a growing preference for both surgical and non-surgical interventions. Non-surgical treatments, including pessaries and pelvic floor muscle therapy, remain the first line of management for mild to moderate cases, while surgical procedures such as colpocleisis, colporrhaphy, sacrocolpopexy, and uterosacral ligament fixation are preferred for severe cases. Innovations in minimally invasive surgical techniques, robotic-assisted procedures, and biocompatible surgical meshes have enhanced precision, safety, and recovery outcomes for patients.
Moreover, increased focus on female health and ongoing R&D in therapeutic devices and materials have positioned POP repair as a rapidly evolving segment within gynecological healthcare. The adoption of technologically advanced solutions ensures better treatment efficacy, reduced complications, and faster post-procedure rehabilitation, contributing to overall market growth.
Drivers
Several factors are propelling the expansion of the POP Repair Market:
- Aging Female Population: With the global rise in elderly women, the prevalence of POP is increasing, boosting demand for corrective treatments.
- Technological Advancements: Innovations in surgical devices, minimally invasive techniques, and pelvic floor rehabilitation equipment improve treatment outcomes.
- Awareness and Education: Growing awareness about female pelvic health encourages early diagnosis and treatment adoption.
- Healthcare Infrastructure Development: Expanding hospitals and specialized female care facilities enhance access to advanced POP repair therapies.
- Preference for Conservative Care: Increasing acceptance of non-surgical treatments, including pessaries and pelvic floor exercises, drives diverse solution adoption.
Business Opportunity
The POP Repair Market presents numerous opportunities for medical device manufacturers, healthcare providers, and investors:
- Emerging Markets: Regions like Asia Pacific and Latin America are witnessing growth due to rising healthcare investments and awareness initiatives.
- Product Innovation: Development of ergonomic pessaries, bio-compatible surgical meshes, and robotic-assisted surgical tools provides differentiation opportunities.
- Strategic Collaborations: Partnerships between medical device manufacturers and healthcare providers can accelerate market penetration.
- Home-Based Care: Telemedicine-enabled pelvic floor therapy and home-use devices create new channels for patient care.
Region Analysis
- North America: Leads the market, supported by advanced healthcare infrastructure, higher awareness, and early adoption of minimally invasive surgeries.
- Europe: A mature market with significant adoption of surgical innovations, favorable reimbursement policies, and strong research initiatives.
- Asia Pacific: Expected to experience rapid growth due to increasing geriatric population, awareness campaigns, and improving access to specialized care.
- Latin America: Growth driven by expanding healthcare infrastructure, improving affordability, and government initiatives supporting women's health.
- Middle East & Africa (MEA): The market is gradually developing with increased investments in healthcare facilities and specialized female care services.
Key Players
Major players shaping the global POP Repair Market include:
- Johnson & Johnson Services, Inc.
- Coloplast A/S
- Dipromed Srl
- Boston Scientific Corporation (American Medical Systems Inc.)
- pfm medical ag
- Betatech Medical
- Promedon Group
- Caldera Medical
- Cook Medical
- MEDGYN PRODUCTS, INC.
- CooperSurgical, Inc.
- DIMA S.L.
- Digitimer Ltd
- Bray Group Ltd
- medesign Ingenieur-Consulting GmbH
- Panpac Medical Corp.
- for.me.sa.
- Bioteque America Inc.
- Bliss GVS Pharma
- Panpac Medical Corporation
- Personal Medical Corporation
- Dr. Arabin GmbH & Co.
- Kangge Medical
- Integra Lifesciences
- Wallach Surgical Devices
- Medesign
Market Segmentation
By Treatment
- Non-surgical
- Pessary
- Pelvic Floor Muscle Therapy
- Surgical
- Colpocleisis
- Colporrhaphy
- Sacrocolpopexy
- Sacrohysteropexy
- Uterosacral or Sacrospinous Ligament Fixation
By Application
- Cystocele
- Urethrocele
- Enterocele
- Uterine Prolapse
- Posterior Vaginal Wall Prolapse (dropped rectum)
By End User
- Hospitals
- Specialized Clinics
- Female Care Facilities
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global Pelvic Organ Prolapse Repair Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Pelvic Organ Prolapse Repair Market Outlook, 2020-2033
- 3.1. Global Pelvic Organ Prolapse Repair Market Outlook, by Treatment, Value (US$ Bn), 2020-2033
- 3.1.1. Non-surgical
- 3.1.2. Pessary
- 3.1.3. Pelvic Floor Muscle Therapy
- 3.1.4. Surgical
- 3.1.5. Colpocleisis
- 3.1.6. Colporrhaphy
- 3.1.7. Sacrocolpopexy
- 3.1.8. Sacrohysteropexy
- 3.1.9. Uterosacral or Sacrospinous Ligament Fixation
- 3.2. Global Pelvic Organ Prolapse Repair Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 3.2.1. Cystocele
- 3.2.2. Urethrocele
- 3.2.3. Enterocele
- 3.2.4. Uterine Prolapse
- 3.2.5. Posterior Vaginal Wall Prolapse (dropped rectum)
- 3.3. Global Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.3.1. Hospitals
- 3.3.2. Specialised Clinics
- 3.3.3. Female Care Facilities
- 3.4. Global Pelvic Organ Prolapse Repair Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America Pelvic Organ Prolapse Repair Market Outlook, 2020-2033
- 4.1. North America Pelvic Organ Prolapse Repair Market Outlook, by Treatment, Value (US$ Bn), 2020-2033
- 4.1.1. Non-surgical
- 4.1.2. Pessary
- 4.1.3. Pelvic Floor Muscle Therapy
- 4.1.4. Surgical
- 4.1.5. Colpocleisis
- 4.1.6. Colporrhaphy
- 4.1.7. Sacrocolpopexy
- 4.1.8. Sacrohysteropexy
- 4.1.9. Uterosacral or Sacrospinous Ligament Fixation
- 4.2. North America Pelvic Organ Prolapse Repair Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 4.2.1. Cystocele
- 4.2.2. Urethrocele
- 4.2.3. Enterocele
- 4.2.4. Uterine Prolapse
- 4.2.5. Posterior Vaginal Wall Prolapse (dropped rectum)
- 4.3. North America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.3.1. Hospitals
- 4.3.2. Specialised Clinics
- 4.3.3. Female Care Facilities
- 4.4. North America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 4.4.2. U.S. Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 4.4.3. U.S. Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 4.4.4. Canada Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 4.4.5. Canada Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 4.4.6. Canada Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe Pelvic Organ Prolapse Repair Market Outlook, 2020-2033
- 5.1. Europe Pelvic Organ Prolapse Repair Market Outlook, by Treatment, Value (US$ Bn), 2020-2033
- 5.1.1. Non-surgical
- 5.1.2. Pessary
- 5.1.3. Pelvic Floor Muscle Therapy
- 5.1.4. Surgical
- 5.1.5. Colpocleisis
- 5.1.6. Colporrhaphy
- 5.1.7. Sacrocolpopexy
- 5.1.8. Sacrohysteropexy
- 5.1.9. Uterosacral or Sacrospinous Ligament Fixation
- 5.2. Europe Pelvic Organ Prolapse Repair Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 5.2.1. Cystocele
- 5.2.2. Urethrocele
- 5.2.3. Enterocele
- 5.2.4. Uterine Prolapse
- 5.2.5. Posterior Vaginal Wall Prolapse (dropped rectum)
- 5.3. Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.3.1. Hospitals
- 5.3.2. Specialised Clinics
- 5.3.3. Female Care Facilities
- 5.4. Europe Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.2. Germany Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.3. Germany Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.4.4. Italy Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.5. Italy Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.6. Italy Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.4.7. France Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.8. France Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.9. France Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.4.10. U.K. Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.11. U.K. Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.12. U.K. Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.4.13. Spain Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.14. Spain Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.15. Spain Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.4.16. Russia Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.17. Russia Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.18. Russia Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.4.19. Rest of Europe Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 5.4.20. Rest of Europe Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 5.4.21. Rest of Europe Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, 2020-2033
- 6.1. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Treatment, Value (US$ Bn), 2020-2033
- 6.1.1. Non-surgical
- 6.1.2. Pessary
- 6.1.3. Pelvic Floor Muscle Therapy
- 6.1.4. Surgical
- 6.1.5. Colpocleisis
- 6.1.6. Colporrhaphy
- 6.1.7. Sacrocolpopexy
- 6.1.8. Sacrohysteropexy
- 6.1.9. Uterosacral or Sacrospinous Ligament Fixation
- 6.2. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 6.2.1. Cystocele
- 6.2.2. Urethrocele
- 6.2.3. Enterocele
- 6.2.4. Uterine Prolapse
- 6.2.5. Posterior Vaginal Wall Prolapse (dropped rectum)
- 6.3. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.3.1. Hospitals
- 6.3.2. Specialised Clinics
- 6.3.3. Female Care Facilities
- 6.4. Asia Pacific Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 6.4.2. China Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 6.4.3. China Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 6.4.4. Japan Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 6.4.5. Japan Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 6.4.6. Japan Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 6.4.7. South Korea Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 6.4.8. South Korea Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 6.4.9. South Korea Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 6.4.10. India Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 6.4.11. India Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 6.4.12. India Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 6.4.13. Southeast Asia Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 6.4.14. Southeast Asia Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 6.4.15. Southeast Asia Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 6.4.16. Rest of SAO Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 6.4.17. Rest of SAO Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 6.4.18. Rest of SAO Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America Pelvic Organ Prolapse Repair Market Outlook, 2020-2033
- 7.1. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Treatment, Value (US$ Bn), 2020-2033
- 7.1.1. Non-surgical
- 7.1.2. Pessary
- 7.1.3. Pelvic Floor Muscle Therapy
- 7.1.4. Surgical
- 7.1.5. Colpocleisis
- 7.1.6. Colporrhaphy
- 7.1.7. Sacrocolpopexy
- 7.1.8. Sacrohysteropexy
- 7.1.9. Uterosacral or Sacrospinous Ligament Fixation
- 7.2. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 7.2.1. Cystocele
- 7.2.2. Urethrocele
- 7.2.3. Enterocele
- 7.2.4. Uterine Prolapse
- 7.2.5. Posterior Vaginal Wall Prolapse (dropped rectum)
- 7.3. Latin America Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.3.1. Hospitals
- 7.3.2. Specialised Clinics
- 7.3.3. Female Care Facilities
- 7.4. Latin America Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 7.4.2. Brazil Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 7.4.3. Brazil Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 7.4.4. Mexico Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 7.4.5. Mexico Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 7.4.6. Mexico Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 7.4.7. Argentina Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 7.4.8. Argentina Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 7.4.9. Argentina Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 7.4.10. Rest of LATAM Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 7.4.11. Rest of LATAM Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 7.4.12. Rest of LATAM Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, 2020-2033
- 8.1. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Treatment, Value (US$ Bn), 2020-2033
- 8.1.1. Non-surgical
- 8.1.2. Pessary
- 8.1.3. Pelvic Floor Muscle Therapy
- 8.1.4. Surgical
- 8.1.5. Colpocleisis
- 8.1.6. Colporrhaphy
- 8.1.7. Sacrocolpopexy
- 8.1.8. Sacrohysteropexy
- 8.1.9. Uterosacral or Sacrospinous Ligament Fixation
- 8.2. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Application, Value (US$ Bn), 2020-2033
- 8.2.1. Cystocele
- 8.2.2. Urethrocele
- 8.2.3. Enterocele
- 8.2.4. Uterine Prolapse
- 8.2.5. Posterior Vaginal Wall Prolapse (dropped rectum)
- 8.3. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.3.1. Hospitals
- 8.3.2. Specialised Clinics
- 8.3.3. Female Care Facilities
- 8.4. Middle East & Africa Pelvic Organ Prolapse Repair Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 8.4.2. GCC Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 8.4.3. GCC Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 8.4.4. South Africa Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 8.4.5. South Africa Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 8.4.6. South Africa Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 8.4.7. Egypt Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 8.4.8. Egypt Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 8.4.9. Egypt Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 8.4.10. Nigeria Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 8.4.11. Nigeria Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 8.4.12. Nigeria Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 8.4.13. Rest of Middle East Pelvic Organ Prolapse Repair Market Outlook, by Treatment, 2020-2033
- 8.4.14. Rest of Middle East Pelvic Organ Prolapse Repair Market Outlook, by Application, 2020-2033
- 8.4.15. Rest of Middle East Pelvic Organ Prolapse Repair Market Outlook, by End User, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Johnson & Johnson Services, Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Coloplast A/S
- 9.4.3. Dipromed Srl
- 9.4.4. pfm medical ag
- 9.4.5. Betatech Medical
- 9.4.6. Promedon Group
- 9.4.7. Caldera Medical
- 9.4.8. Cook Medical
- 9.4.9. MEDGYN PRODUCTS, INC.
- 9.4.10. CooperSurgical, Inc.
- 9.4.1. Johnson & Johnson Services, Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
샘플 요청 목록